| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Pulmonary Division (Drs. Luna, Videla, Nogueira, Diaz Fuenzalida and Gené), Department of Medicine, Hospital de Clínicas "José de San Martín," and Clinical Biochemistry Department (Drs. Famiglietti and Absi), Faculty of Biochemistry, University of Buenos Aires, Argentina.
Correspondence to: Carlos M. Luna, MD, Acevedo 1070, Banfield 1828, Buenos Aires, Argentina; e-mail: cymluna{at}fmed.uba.ar
Objective: To survey the etiology and epidemiology of community-acquired pneumonia (CAP) in relation to age, comorbidity, and severity and to investigate prognostic factors.
Design: Prospective epidemiologic study, single center.
Setting: University hospital at Buenos Aires, Argentina.
Patients: Outpatients and inpatients fulfilling clinical criteria of CAP.
Interventions: Systematic laboratory evaluation for determining the etiology, and clinical evaluation stratifying patients into mild, moderate, and severe CAP (groups 1 to 3), a clinical rule used for hospitalization.
Results: During a 12-month period, 343 patients (mean age, 64.4 years; range, 18 to 102 years) were evaluated. We found 167 microorganisms in 144 cases (yield, 42%). Streptococcus pneumoniae, the most common pathogen, was isolated in 35 cases (24%). Mycoplasma pneumoniae, present in 19 (13%), was second in frequency in group 1; Haemophilus influenzae, present in 17 cases (12%), was second in group 2; and Chlamydia pneumoniae, present in 12 cases (8%), was second in group 3. Etiology could not be determined on the basis of clinical presentation; identifying the etiology had no impact on mortality. Some findings were associated with specific causative organisms and outcome. A significantly lower number of nonsurvivors received adequate therapy (50% vs 77%).
Conclusions: Age, comorbidities, alcohol abuse, and smoking were related with distinct etiologies. PaO2 to fraction of inspired oxygen ratio < 250, aerobic Gram-negative pathogen, chronic renal failure, Glasgow score < 15, malignant neoplasm, and aspirative pneumonia were associated with mortality by multivariate analysis. Local microbiologic data could be of help in tailoring therapeutic guidelines to the microbiologic reality at different settings. The stratification schema and the clinical rule used for hospitalization were useful.
Key Words: Argentina • comorbidities • community-acquired pneumonia • epidemiology • etiology • guidelines • mortality • outcome • South America • therapy
This article has been cited by other articles:
|
|
 |
|
  A. Diaz, P. Barria, M. Niederman, M. I. Restrepo, J. Dreyse, G. Fuentes, B. Couble, and F. Saldias Etiology of Community-Acquired Pneumonia in Hospitalized Patients in Chile: The Increasing Prevalence of Respiratory Viruses Among Classic Pathogens Chest, March 1, 2007; 131(3): 779 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Masia, F. Gutierrez, C. Shum, S. Padilla, J. C. Navarro, E. Flores, and I. Hernandez Usefulness of Procalcitonin Levels in Community-Acquired Pneumonia According to the Patients Outcome Research Team Pneumonia Severity Index Chest, October 1, 2005; 128(4): 2223 - 2229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Luna Blood Cultures in Community-Acquired Pneumonia: Are We Ready To Quit? Chest, April 1, 2003; 123(4): 977 - 978. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Metlay and M. J. Fine Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia Ann Intern Med, January 21, 2003; 138(2): 109 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rello, M. Bodi, D. Mariscal, M. Navarro, E. Diaz, M. Gallego, and J. Valles Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia Chest, January 1, 2003; 123(1): 174 - 180. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
